Second generation Chimeric Antigen Receptor (CAR) T-cells have revolutionised the treatment of B-cell and plasma cell malignancies, achieving potent and durable responses across a number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback